Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | |
| Cash Flows From Operating Activities | |
| Net Income | -1,726 |
| Accounts receivable | -18 |
| Other Working Capital | 58 |
| Other Operating Activity | 172 |
| Operating Cash Flow | $-1,515 |
| Cash Flows From Investing Activities | |
| PPE Investments | -4 |
| Investing Cash Flow | $-4 |
| Cash Flows From Financing Activities | |
| Common Stock Issued | 2,385 |
| Other Financing Activity | -199 |
| Financing Cash Flow | $2,187 |
| Beginning Cash Position | 2 |
| End Cash Position | 670 |
| Net Cash Flow | $669 |
| Free Cash Flow | |
| Operating Cash Flow | -1,515 |
| Capital Expenditure | -4 |
| Free Cash Flow | -1,518 |